The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs
In clinical trials, treatment proved more effective than other therapies evaluated
ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
Subscribe To Our Newsletter & Stay Updated
